NCT06573099

A Real-World Study on Extranodal Lymphoma

• Status: Not Yet Recruiting
• Phase: —
• Study type: Observational
• Enrollment: 5,000 (estimated)
• Sponsor: Ruijin Hospital · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: —

Summary

The aim of this study is to prospectively collect clinical information on patients with extranodal lymphoma, and to explore the best therapeutic strategies in the real-world population.

Detailed description

Lymphoma is a common hematological malignancy. Many different pathologic types of lymphoma can originate in extranodal organs or be associated with extranodal organ involvement. For lymphoma with extranodal involvement, conventional regimens often cannot provide satisfactory results for patients. This study aims to prospectively collect clinical information on patients with extranodal DLBCL, including the distribution of involved sites, clinical and molecular characteristics of different lymphoma subtypes, clinical treatment protocols, and prognosis, to explore the the best therapeutic strategies in the real-world population.

Conditions

• Lymphoma
• Lymphoma, B-Cell
• Lymphoma, Non-Hodgkin
• Extranodal Lymphoma
• Diffuse Large B Cell Lymphoma

Interventions

Type	Name	Description
OTHER	No interventions need to be specified for this study	No interventions need to be specified for this study

Timeline

• Start date: 2024-09-01
• Primary completion: 2027-09-01
• Completion: 2029-09-01
• First posted: 2024-08-27
• Last updated: 2024-08-27